175 related articles for article (PubMed ID: 25979597)
1. Loss of heterozygosity in tumor tissue in hormonal receptor genes is associated with poor prognostic criteria in breast cancer.
Iobagiu C; Lambert C; Raica M; Lima S; Khaddage A; Peoc'h M; Genin C
Cancer Genet; 2015 Apr; 208(4):135-42. PubMed ID: 25979597
[TBL] [Abstract][Full Text] [Related]
2. Alterations of the 16q22.1 and 16q24.3 chromosomal loci in sporadic invasive breast carcinomas: correlation with proliferative activity, ploidy and hormonal status of the tumors.
Kouvaraki M; Gorgoulis VG; Rassidakis GZ; Liodis P; Koutroumbi E; Markopoulos C; Gogas J; Kittas C
Anticancer Res; 2001; 21(2A):991-9. PubMed ID: 11396193
[TBL] [Abstract][Full Text] [Related]
3. Differential patterns of allelic loss in estrogen receptor-positive infiltrating lobular and ductal breast cancer.
Loo LW; Ton C; Wang YW; Grove DI; Bouzek H; Vartanian N; Lin MG; Yuan X; Lawton TL; Daling JR; Malone KE; Li CI; Hsu L; Porter PL
Genes Chromosomes Cancer; 2008 Dec; 47(12):1049-66. PubMed ID: 18720524
[TBL] [Abstract][Full Text] [Related]
4. High incidence and frequency of LOH are associated with aggressive features of high-grade HER2 and triple-negative breast cancers.
Tokunaga E; Okada S; Yamashita N; Akiyoshi S; Kitao H; Morita M; Kakeji Y; Maehara Y
Breast Cancer; 2012 Apr; 19(2):161-9. PubMed ID: 21063923
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity at chromosome 6q in preinvasive and early invasive breast carcinomas.
Chappell SA; Walsh T; Walker RA; Shaw JA
Br J Cancer; 1997; 75(9):1324-9. PubMed ID: 9155053
[TBL] [Abstract][Full Text] [Related]
6. Correlation of her-2/neu gene amplification with other prognostic and predictive factors in female breast carcinoma.
Ariga R; Zarif A; Korasick J; Reddy V; Siziopikou K; Gattuso P
Breast J; 2005; 11(4):278-80. PubMed ID: 15982396
[TBL] [Abstract][Full Text] [Related]
7. The estrogen receptor coactivator AIB1 is a new putative prognostic biomarker in ER-positive/HER2-negative invasive lobular carcinoma of the breast.
Narbe U; Sjöström M; Forsare C; Bendahl PO; Alkner S; Leeb-Lundberg LMF; Lövgren K; Rydén L; Ingvar C; Fernö M
Breast Cancer Res Treat; 2019 Jun; 175(2):305-316. PubMed ID: 30796653
[TBL] [Abstract][Full Text] [Related]
8. Allelic loss of chromosome 3p24 correlates with tumor progression rather than with retinoic acid receptor beta2 expression in breast carcinoma.
Yang Q; Yoshimura G; Nakamura M; Nakamura Y; Shan L; Suzuma T; Tamaki T; Umemura T; Mori I; Kakudo K
Breast Cancer Res Treat; 2001 Nov; 70(1):39-45. PubMed ID: 11767003
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer.
Järvinen TA; Pelto-Huikko M; Holli K; Isola J
Am J Pathol; 2000 Jan; 156(1):29-35. PubMed ID: 10623650
[TBL] [Abstract][Full Text] [Related]
10. Biological and clinical significance of loss of heterozygosity at the INPP4B gene locus in Japanese breast cancer.
Tokunaga E; Yamashita N; Kitao H; Tanaka K; Taketani K; Inoue Y; Saeki H; Oki E; Oda Y; Maehara Y
Breast; 2016 Feb; 25():62-8. PubMed ID: 26577950
[TBL] [Abstract][Full Text] [Related]
11. Combined profile of the tandem repeats CAG, TA and CA of the androgen and estrogen receptor genes in breast cancer.
Anghel A; Raica M; Marian C; Ursoniu S; Mitrasca O
J Cancer Res Clin Oncol; 2006 Nov; 132(11):727-33. PubMed ID: 16791593
[TBL] [Abstract][Full Text] [Related]
12. Quantitation of androgen receptor gene expression in sporadic breast tumors by real-time RT-PCR: evidence that MYC is an AR-regulated gene.
Bièche I; Parfait B; Tozlu S; Lidereau R; Vidaud M
Carcinogenesis; 2001 Sep; 22(9):1521-6. PubMed ID: 11532875
[TBL] [Abstract][Full Text] [Related]
13. Detailed deletion mapping in sporadic breast cancer at chromosomal region 17p13 distal to the TP53 gene: association with clinicopathological parameters.
Seitz S; Poppe K; Fischer J; Nothnagel A; Estévez-Schwarz L; Haensch W; Schlag PM; Scherneck S
J Pathol; 2001 Jul; 194(3):318-26. PubMed ID: 11439364
[TBL] [Abstract][Full Text] [Related]
14. Expression of cyclooxygenase-2 and 12-lipoxygenase in human breast cancer and their relationship with HER-2/neu and hormonal receptors: impact on prognosis and therapy.
Mohammad AM; Abdel HA; Abdel W; Ahmed AM; Wael T; Eiman G
Indian J Cancer; 2006; 43(4):163-8. PubMed ID: 17192687
[TBL] [Abstract][Full Text] [Related]
15. [Microsatellite instability and allele-specific chromosome 3p deletion in breast cancer and precancerous lesions].
Fu Q; Yao GY; Tang XL; Chen LR; Zheng ZX
Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):34-40. PubMed ID: 17575691
[TBL] [Abstract][Full Text] [Related]
16. Expression of androgen receptor in breast cancer and its significance as a prognostic factor.
Yu Q; Niu Y; Liu N; Zhang JZ; Liu TJ; Zhang RJ; Wang SL; Ding XM; Xiao XQ
Ann Oncol; 2011 Jun; 22(6):1288-1294. PubMed ID: 21109569
[TBL] [Abstract][Full Text] [Related]
17. Patterns of allelic loss on chromosome 17 in sporadic breast carcinomas detected by fluorescent-labeled microsatellite analysis.
Niederacher D; Picard F; van Roeyen C; An HX; Bender HG; Beckmann MW
Genes Chromosomes Cancer; 1997 Mar; 18(3):181-92. PubMed ID: 9071571
[TBL] [Abstract][Full Text] [Related]
18. Correlation between CpG methylation profiles and hormone receptor status in breast cancers.
Feng W; Shen L; Wen S; Rosen DG; Jelinek J; Hu X; Huan S; Huang M; Liu J; Sahin AA; Hunt KK; Bast RC; Shen Y; Issa JP; Yu Y
Breast Cancer Res; 2007; 9(4):R57. PubMed ID: 17764565
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of androgen receptor expression in invasive breast cancer: transcriptomic and protein expression analysis.
Aleskandarany MA; Abduljabbar R; Ashankyty I; Elmouna A; Jerjees D; Ali S; Buluwela L; Diez-Rodriguez M; Caldas C; Green AR; Ellis IO; Rakha EA
Breast Cancer Res Treat; 2016 Sep; 159(2):215-27. PubMed ID: 27514395
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity at 13q14 correlates with RB1 gene underexpression in human breast cancer.
Bièche I; Lidereau R
Mol Carcinog; 2000 Nov; 29(3):151-8. PubMed ID: 11108660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
